Cargando…

A preliminary study of schema therapy for young adults with high-functioning autism spectrum disorder: a single-arm, uncontrolled trial

OBJECTIVE: Psychological problems associated with isolation and mistrust are common among young adults with autism spectrum disorder (ASD). Schema therapy (ST) has recently been shown to be effective against chronic personality problems of various mental disorders, including personality disorders. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Oshima, Fumiyo, Murata, Tomokazu, Ohtani, Toshiyuki, Seto, Mikuko, Shimizu, Eiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082897/
https://www.ncbi.nlm.nih.gov/pubmed/33926531
http://dx.doi.org/10.1186/s13104-021-05556-1
_version_ 1783685925448974336
author Oshima, Fumiyo
Murata, Tomokazu
Ohtani, Toshiyuki
Seto, Mikuko
Shimizu, Eiji
author_facet Oshima, Fumiyo
Murata, Tomokazu
Ohtani, Toshiyuki
Seto, Mikuko
Shimizu, Eiji
author_sort Oshima, Fumiyo
collection PubMed
description OBJECTIVE: Psychological problems associated with isolation and mistrust are common among young adults with autism spectrum disorder (ASD). Schema therapy (ST) has recently been shown to be effective against chronic personality problems of various mental disorders, including personality disorders. This pilot clinical trial aimed to explore the feasibility and acceptability of ST in young adults with high-functioning ASD. RESULTS: Following the intervention, a significant reduction in early maladaptive schemas and improvements in quality of life and social adjustment were observed. ST may be feasible and is applicable to young adults with HF-ASD. Trial registration UMIN000014535; registered on July 11, 2014 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13104-021-05556-1.
format Online
Article
Text
id pubmed-8082897
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80828972021-04-29 A preliminary study of schema therapy for young adults with high-functioning autism spectrum disorder: a single-arm, uncontrolled trial Oshima, Fumiyo Murata, Tomokazu Ohtani, Toshiyuki Seto, Mikuko Shimizu, Eiji BMC Res Notes Research Note OBJECTIVE: Psychological problems associated with isolation and mistrust are common among young adults with autism spectrum disorder (ASD). Schema therapy (ST) has recently been shown to be effective against chronic personality problems of various mental disorders, including personality disorders. This pilot clinical trial aimed to explore the feasibility and acceptability of ST in young adults with high-functioning ASD. RESULTS: Following the intervention, a significant reduction in early maladaptive schemas and improvements in quality of life and social adjustment were observed. ST may be feasible and is applicable to young adults with HF-ASD. Trial registration UMIN000014535; registered on July 11, 2014 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13104-021-05556-1. BioMed Central 2021-04-29 /pmc/articles/PMC8082897/ /pubmed/33926531 http://dx.doi.org/10.1186/s13104-021-05556-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Note
Oshima, Fumiyo
Murata, Tomokazu
Ohtani, Toshiyuki
Seto, Mikuko
Shimizu, Eiji
A preliminary study of schema therapy for young adults with high-functioning autism spectrum disorder: a single-arm, uncontrolled trial
title A preliminary study of schema therapy for young adults with high-functioning autism spectrum disorder: a single-arm, uncontrolled trial
title_full A preliminary study of schema therapy for young adults with high-functioning autism spectrum disorder: a single-arm, uncontrolled trial
title_fullStr A preliminary study of schema therapy for young adults with high-functioning autism spectrum disorder: a single-arm, uncontrolled trial
title_full_unstemmed A preliminary study of schema therapy for young adults with high-functioning autism spectrum disorder: a single-arm, uncontrolled trial
title_short A preliminary study of schema therapy for young adults with high-functioning autism spectrum disorder: a single-arm, uncontrolled trial
title_sort preliminary study of schema therapy for young adults with high-functioning autism spectrum disorder: a single-arm, uncontrolled trial
topic Research Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082897/
https://www.ncbi.nlm.nih.gov/pubmed/33926531
http://dx.doi.org/10.1186/s13104-021-05556-1
work_keys_str_mv AT oshimafumiyo apreliminarystudyofschematherapyforyoungadultswithhighfunctioningautismspectrumdisorderasinglearmuncontrolledtrial
AT muratatomokazu apreliminarystudyofschematherapyforyoungadultswithhighfunctioningautismspectrumdisorderasinglearmuncontrolledtrial
AT ohtanitoshiyuki apreliminarystudyofschematherapyforyoungadultswithhighfunctioningautismspectrumdisorderasinglearmuncontrolledtrial
AT setomikuko apreliminarystudyofschematherapyforyoungadultswithhighfunctioningautismspectrumdisorderasinglearmuncontrolledtrial
AT shimizueiji apreliminarystudyofschematherapyforyoungadultswithhighfunctioningautismspectrumdisorderasinglearmuncontrolledtrial
AT oshimafumiyo preliminarystudyofschematherapyforyoungadultswithhighfunctioningautismspectrumdisorderasinglearmuncontrolledtrial
AT muratatomokazu preliminarystudyofschematherapyforyoungadultswithhighfunctioningautismspectrumdisorderasinglearmuncontrolledtrial
AT ohtanitoshiyuki preliminarystudyofschematherapyforyoungadultswithhighfunctioningautismspectrumdisorderasinglearmuncontrolledtrial
AT setomikuko preliminarystudyofschematherapyforyoungadultswithhighfunctioningautismspectrumdisorderasinglearmuncontrolledtrial
AT shimizueiji preliminarystudyofschematherapyforyoungadultswithhighfunctioningautismspectrumdisorderasinglearmuncontrolledtrial